Features of neurological manifestations of the COVID-19 in children and adults
The number of COVID-19 patients is increasing worldwide and the number of patients with neurological manifestations of a new coronavirus infection is increasing as well. Pathognomonic for COVID-19 is the presence of cephalgic syndrome, infectious-toxic encephalopathy, hypo- and anosmia and ageusia. Inducing of pathological autoimmune response contributes to the development of Miller Fischer and Guillain-Barré syndrome. Hyperergic reaction with the generation of the so-called «cytokine storm» provokes multisystem hemorrhagic complications such as Kawasaki disease and acute necrotizing hemorrhagic encephalopathy. There is also a special form of COVID-19-associated stroke. Almost all post-COVID-19 patients complain of severe fatigue, emotional lability, and sometimes have features of asthenic-neurotic, anxiety-phobic disorders and apato-abulic syndromes, which require rehabilitation measures, as well as courses of restorative neurotrophic and nootropic therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:120 |
|---|---|
| Enthalten in: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 120(2020), 9 vom: 30., Seite 114-120 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Osobennosti nevrologicheskikh proyavlenii COVID-19 u detei i vzroslykh |
|---|
| Beteiligte Personen: |
Kholin, A A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anosmia |
|---|
| Anmerkungen: |
Date Completed 23.10.2020 Date Revised 31.05.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/jnevro2020120091114 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316507148 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316507148 | ||
| 003 | DE-627 | ||
| 005 | 20231225161230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/jnevro2020120091114 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1054.xml |
| 035 | |a (DE-627)NLM316507148 | ||
| 035 | |a (NLM)33081456 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Kholin, A A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Features of neurological manifestations of the COVID-19 in children and adults |
| 246 | 3 | 3 | |a Osobennosti nevrologicheskikh proyavlenii COVID-19 u detei i vzroslykh |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.10.2020 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The number of COVID-19 patients is increasing worldwide and the number of patients with neurological manifestations of a new coronavirus infection is increasing as well. Pathognomonic for COVID-19 is the presence of cephalgic syndrome, infectious-toxic encephalopathy, hypo- and anosmia and ageusia. Inducing of pathological autoimmune response contributes to the development of Miller Fischer and Guillain-Barré syndrome. Hyperergic reaction with the generation of the so-called «cytokine storm» provokes multisystem hemorrhagic complications such as Kawasaki disease and acute necrotizing hemorrhagic encephalopathy. There is also a special form of COVID-19-associated stroke. Almost all post-COVID-19 patients complain of severe fatigue, emotional lability, and sometimes have features of asthenic-neurotic, anxiety-phobic disorders and apato-abulic syndromes, which require rehabilitation measures, as well as courses of restorative neurotrophic and nootropic therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Guillain—Barré syndrome | |
| 650 | 4 | |a Kawasaki disease | |
| 650 | 4 | |a Miller Fisher syndrome | |
| 650 | 4 | |a SARS CoV-2 | |
| 650 | 4 | |a anosmia | |
| 650 | 4 | |a encephalopathy | |
| 650 | 4 | |a headache | |
| 650 | 4 | |a stroke | |
| 700 | 1 | |a Zavadenko, N N |e verfasserin |4 aut | |
| 700 | 1 | |a Nesterovskiy, Yu E |e verfasserin |4 aut | |
| 700 | 1 | |a Kholina, E A |e verfasserin |4 aut | |
| 700 | 1 | |a Zavadenko, A N |e verfasserin |4 aut | |
| 700 | 1 | |a Khondkaryan, G Sh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova |d 1997 |g 120(2020), 9 vom: 30., Seite 114-120 |w (DE-627)NLM074605267 |x 1997-7298 |7 nnns |
| 773 | 1 | 8 | |g volume:120 |g year:2020 |g number:9 |g day:30 |g pages:114-120 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/jnevro2020120091114 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 120 |j 2020 |e 9 |b 30 |h 114-120 | ||